Review: taking Vitamin d and Copaxone together


Summary

Drug interactions are reported among people who take Vitamin d and Copaxone together. This review analyzes the effectiveness and drug interactions between Vitamin d and Copaxone. It is created by eHealthMe based on reports of 788 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vitamin D

Vitamin d has active ingredients of ergocalciferol. It is often used in vitamin supplementation. (latest outcomes from Vitamin d 47,419 users)

Copaxone

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. (latest outcomes from Copaxone 25,477 users)

On Sep, 14, 2016

788 people who take Vitamin D, Copaxone are studied.


Number of reports submitted per year:

Vitamin d and Copaxone drug interactions.

Drug effectiveness over time:

Vitamin D:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 100.0% - (4 of 4 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Copaxone:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 100.0% - (4 of 4 people)
  • 10+ years: 0.0% - (0 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Vitamin D:
  • female: 53.0% - (7 of 13 people)
  • male: 100.0% - (1 of 1 people)
Copaxone:
  • female: 33.0% - (6 of 18 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Vitamin D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 50.0% - (2 of 4 people)
  • 60+: 100.0% - (1 of 1 people)
Copaxone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 14.0% - (1 of 7 people)
  • 60+: 33.0% - (1 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • urticaria
  • dizziness
  • fall
  • gait disturbance
  • headache
  • arthralgia
  • back pain
  • balance disorder
  • chest pain
  • convulsion
1 - 6 months:
  • chest pain
  • injection site mass
  • injection site pain
  • nausea
  • anaphylactic reaction
  • dyspnoea
  • headache
  • injection site oedema
  • injection site pruritus
  • injection site swelling
6 - 12 months:
  • headache
  • hypoaesthesia
  • pain in extremity
  • paraesthesia
  • peripheral swelling
  • abortion
  • adverse drug reaction
  • anemia
  • ankle fracture
  • ataxia
1 - 2 years:
  • angioedema
  • cellulitis
  • dermatitis
  • drug ineffective
  • eye swelling
  • hangover
  • mechanical urticaria
  • shingles
  • skin lesion
  • tiredness
2 - 5 years:
  • arthralgia
  • abdominal pain
  • paraesthesia
  • asthenia
  • gait disturbance
  • pain
  • sciatica
  • abdominal discomfort
  • alopecia
  • fall
5 - 10 years:
  • dizziness
  • fatigue
  • irregular heartbeat
  • weak pulse
  • gait disturbance
  • asthenia
  • balance disorder
  • central nervous system lesion
  • cystitis
  • disease progression
10+ years:
  • anxiety and stress
  • bipolar 2
  • bipolar ii disorder
  • migraine
  • multiple sclerosis
  • blood chloride abnormal
  • diarrhoea
  • dizziness
  • fatigue
  • feeling abnormal
not specified:
  • gait disturbance
  • multiple sclerosis relapse
  • fatigue
  • dizziness
  • drug ineffective
  • balance disorder
  • insomnia
  • fall
  • nausea
  • headache

Most common drug interactions by gender *:

female:
  • gait disturbance
  • multiple sclerosis relapse
  • fatigue
  • dizziness
  • headache
  • nausea
  • insomnia
  • balance disorder
  • hypoaesthesia
  • asthenia
male:
  • gait disturbance
  • drug ineffective
  • multiple sclerosis relapse
  • fatigue
  • fall
  • dizziness
  • balance disorder
  • hypoaesthesia
  • asthenia
  • insomnia

Most common drug interactions by age *:

0-1:
  • foetal exposure during pregnancy
  • pyloric stenosis
  • respiratory disorder neonatal
2-9:
  • choking
  • depressed level of consciousness
10-19:
  • blindness
  • diplopia
  • eye movement disorder
  • hypoaesthesia
  • injection site pain
  • limb injury
  • paraesthesia
20-29:
  • nausea
  • urticaria
  • dizziness
  • drug ineffective
  • hot flush
  • incontinence
  • injection site erythema
  • injection site reaction
  • injection site swelling
  • multiple sclerosis relapse
30-39:
  • dizziness
  • injection site pain
  • headache
  • arthralgia
  • fatigue
  • loss of consciousness
  • hypoaesthesia
  • erythema
  • multiple sclerosis
  • multiple sclerosis relapse
40-49:
  • multiple sclerosis relapse
  • insomnia
  • drug ineffective
  • fatigue
  • dizziness
  • balance disorder
  • gait disturbance
  • headache
  • fall
  • pain
50-59:
  • gait disturbance
  • nausea
  • fatigue
  • multiple sclerosis relapse
  • dizziness
  • fall
  • insomnia
  • headache
  • muscular weakness
  • diarrhoea
60+:
  • gait disturbance
  • urinary tract infection
  • fall
  • dizziness
  • multiple sclerosis relapse
  • asthenia
  • hypoaesthesia
  • paraesthesia
  • balance disorder
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vitamin d and Copaxone?

Can you answer these questions?

More questions for: Vitamin d, Copaxone

You may be interested in these reviews

More reviews for: Vitamin d, Copaxone

On eHealthMe, Vitamin d (ergocalciferol) is often used to treat vitamin supplementation. Copaxone (glatiramer acetate) is often used to treat multiple sclerosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.